Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Accounts Payables (2016 - 2026)

Nutex Health (NUTX) has disclosed Accounts Payables for 17 consecutive years, with $3.9 million as the latest value for Q1 2026.

  • For Q1 2026, Accounts Payables rose 210.8% year-over-year to $3.9 million; the TTM value through Mar 2026 reached $3.9 million, up 210.8%, while the annual FY2025 figure was $3.1 million, 285.11% up from the prior year.
  • Accounts Payables hit $3.9 million in Q1 2026 for Nutex Health, up from $3.1 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $28.1 million in Q2 2025 and bottomed at -$3.5 million in Q1 2025.
  • Average Accounts Payables over 5 years is $7.7 million, with a median of $3.9 million recorded in 2026.
  • Year-over-year, Accounts Payables skyrocketed 1999.91% in 2023 and then plummeted 453.8% in 2025.
  • Nutex Health's Accounts Payables stood at $900000.0 in 2022, then surged by 1999.91% to $18.9 million in 2023, then crashed by 95.74% to $806000.0 in 2024, then skyrocketed by 285.11% to $3.1 million in 2025, then rose by 26.29% to $3.9 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $3.9 million, $3.1 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.